Expression and Significance of ER,PR,Her-2 and p53 in Ovarian Epithelial Carcinoma
Liu Jianmin
Abstract
Liu Jianmin
Abstract
Objective To explore the expression and significance of ER,PR,Her-2 and p53 in ovarian epithelial carcinoma.Methods The expression of ER,PR,Her-2,p53 in ovarian epithelial carcinoma were detected by immunohistochemistry method,and analyzing ER,PR,Her-2,P53's relation with pathological mechanism microanatomy type,microanatomy classifies and clinical periodization.Results The positive expressions of ER,PR,Her-2,p53 in 43 patients with epithelial ovarian cancer were 55.8%,60.5%,23.3% and 67.4%;The expressions of ER has no relation with pathological mechanism microanatomy type,microanatomy classifies and clinical periodization.The expressions of PR,Her-2,p53 had relation with clinical periodization.The expression level of PR in stageⅠ~Ⅱ was higher than of stage Ⅲ~Ⅳ(P0.05);The expression level of Her-2 and p53 in stage Ⅲ~Ⅳ was higher than of stageⅠ~Ⅱ(P0.05).Conclusion The expression of ER,PR,Her-2 and p53 can help estimate ovary cancer prognosis and make rational therapeutic schedule for patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the expression and significance of ER,PR,Her-2 and p53 in ovarian epithelial carcinoma.Methods The expression of ER,PR,Her-2,p53 in ovarian epithelial carcinoma were detected by immunohistochemistry method,and analyzing ER,PR,Her-2,P53's relation with pathological mechanism microanatomy type,microanatomy classifies and clinical periodization.Results The positive expressions of ER,PR,Her-2,p53 in 43 patients with epithelial ovarian cancer were 55.8%,60.5%,23.3% and 67.4%;The expressions of ER has no relation with pathological mechanism microanatomy type,microanatomy classifies and clinical periodization.The expressions of PR,Her-2,p53 had relation with clinical periodization.The expression level of PR in stageⅠ~Ⅱ was higher than of stage Ⅲ~Ⅳ(P0.05);The expression level of Her-2 and p53 in stage Ⅲ~Ⅳ was higher than of stageⅠ~Ⅱ(P0.05).Conclusion The expression of ER,PR,Her-2 and p53 can help estimate ovary cancer prognosis and make rational therapeutic schedule for patients.
Key concepts: Medicine, Immunohistochemistry, Periodization, Stage (stratigraphy), Pathological, Ovarian cancer, Ovary, Clinical significance